Covid Update: Get Covaxin, Covishield at Rs 225 - Price slash of Covaxin and Covishield was announced after the government allowed all above 18 years of age can get booster dose from April 10.
India s drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, official sources said. The approval was granted under the New Drugs and Clinical Trials Rules, 2019. Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting. Adverse event following immunisation will continue to be monitored. The Drugs Controller
Covisheild, Covaxin price likely to be capped at Rs 275 per dose after DCGI approval - The price of Covisheild and Covaxin will most likely be capped at Rs 275 per dose after getting market approval from DCGI.
The government Friday said there is no need to panic on the need for an immediate change in the dosage interval of Covishield vaccine, underlining that reducing the time gap requires proper scientific study in the Indian scenario.